Unclaimed Scholar Profile
Are you Khalid El Bairi? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at Université Mohammed VI PolytechniqueASIDASID-7585-5972-2743 orcid.org/0000-0002-8414-4145
Khalid El Bairi
Université Mohammed VI Polytechnique•Morocco
Faculty researcher at Université Mohammed VI Polytechnique (MA), specializing in Agricultural, Environmental & Life Sciences. [Discipline: Agricultural, Environmental & Life Sciences] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: North Africa]
#Ovarian cancer diagnosis and treatment#BRCA gene mutations in cancer#Breast Cancer Treatment Studies#Academic integrity and plagiarism
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 7,552 | 3,625 |
| h-index | 22 | 17 |
| i10-index | 31 | 22 |
Annual Citation Growth
Verified Citations / Year0
2020363
2021+40%508
2022+29%653
2023+33%870
2024-8%798
2025-45%435
2026Scholarship Distribution & Proportions92 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (6,193) • 18% Global Research Impact (1,359)
92 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (92)
Natural products in drug discovery: advances and opportunities
DOI: 10.1038/s41573-020-00114-z Verified Peer-Reviewed
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
Published in npj Breast Cancer•2021
DOI: 10.1038/s41523-021-00346-1 Verified Peer-Reviewed
The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice
Published in The Journal of Pathology•2020
DOI: 10.1002/path.5406 Verified Peer-Reviewed
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
Published in npj Breast Cancer•2020
DOI: 10.1038/s41523-020-0156-0 Verified Peer-Reviewed
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
Published in npj Breast Cancer•2020
DOI: 10.1038/s41523-020-0154-2 Verified Peer-Reviewed
Showing 1 – 5 of 92 publications
1 / 19